Synthetic Biologics, Inc. (SYN)
EBITDA Margin
829.88%
TTM · Period ending:
SYN EBITDA Margin
Latest reported829.88%period ending
Latest reported829.88%period ending
SYN TTM EBITDA Margin (-1460.00% → 829.88%)
TTM ebitda margin
High-resolution chart · PNG
SYN ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 829.8814% | |
| 1,064.2035% | |
| 2,174.0569% | |
| -352.252% | |
| -325.8293% | |
| -71.486% | |
| -42.4186% | |
| -60.1129% | |
| -61.9854% | |
| -2,033.2745% | |
| -3,240.6261% | |
| -6,194.3976% | |
| 35,215.5786% | |
| 38,039.0865% | |
| 38,287.0477% | |
| 37,712.6449% | |
| -19,809.4533% | |
| -47,284.5231% | |
| -72,284.5231% | |
| 460,837.75% | |
| 34,882.3576% | |
| 17,261.42% | |
| -7,658.9494% | |
| -87,717.1% | |
| -107,910.77% | |
| -120,763.05% | |
| -1,611.4887% | |
| -1,099.3875% | |
| -750.8095% | |
| -607.9275% | |
| -1,060.3318% | |
| -1,161.1234% | |
| -2,964.8036% | |
| -2,724.6524% | |
| -2,813.5182% | |
| -2,848.1407% | |
| -1,566.6667% | |
| -1,466.6667% | |
| -633.3333% | |
| -800% | |
| -540% | |
| -610% | |
| -1,242.8571% | |
| -1,314.2857% | |
| -4,900% | |
| -1,357.1429% | |
| -1,114.2857% | |
| -971.4286% | |
| -825% | |
| -2,393.3333% | |
| -2,490% | |
| -2,420% | |
| -2,360% | |
| -2,183.3333% | |
| -2,066.6667% | |
| -1,703.3333% | |
| -1,530% | |
| -1,480% | |
| -1,100% | |
| -1,100% | |
| -873.3333% | |
| -655% | |
| -1,460% |